Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Argye Elizabeth Hillis MD, MA Associate Editor

Nina F. Schor MD, PhD Advisory Board

See All Experts

featured

Published in Neurology

Journal Scan / Research · July 17, 2024

Tau PET for Predicting Dementia in Individuals With Mild Cognitive Impairment

JAMA Neurology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Revised Criteria for Diagnosis and Staging of Alzheimer's Disease
Accuracy of Tau vs Amyloid PET Visual Reads for the Differential Diagnosis of Neurodegenerative Disorders

JAMA Neurology

Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment

JAMA Neurol 2024 Jun 10;[EPub Ahead of Print], C Groot, R Smith, LE Collij, SE Mastenbroek, E Stomrud, AP Binette, A Leuzy, S Palmqvist, N Mattsson-Carlgren, O Strandberg, H Cho, CH Lyoo, GB Frisoni, DE Peretti, V Garibotto, R La Joie, DN Soleimani-Meigooni, G Rabinovici, R Ossenkoppele, O Hansson

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Notice to Our Valued Users

Tau PET for Predicting Dementia in Individuals With Mild Cognitive Impairment

Additional Info

Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment

Further Reading

Final Note From the Neurology Editors

Association of Health and Lifestyle Factors With Dementia Risk in Former Professional Soccer Players

Association of the Cervical Canal Area With Disability and Progression in People With MS

Directional Subthalamic Deep Brain Stimulation Better Improves Gait and Balance Disorders in Patients With Parkinson's Disease

Induction Cyclophosphamide With Maintenance Immunosuppression for High-Risk Myasthenia Gravis

Non-Invasive Continuous Oral Delivery of Solid Levodopa–Carbidopa for the Management of Parkinson's Disease

Low-Frequency Deep Brain Stimulation During Non-REM Sleep Modifies Memory Retention in Patients With Parkinson's Disease

Toward Personalized Dosing of B-Cell–Depleting Therapy

Safety and Efficacy of Intravenous Recombinant Human Prourokinase for Acute Ischaemic Stroke Within 4.5 Hours After Stroke Onset

Hypogammaglobulinemia and Severe Infections in Patients With MS on Anti-CD20 Agents

Risk of Hypertension in Patients With MS Treated With Teriflunomide vs Dimethyl Fumarate

Recently Updated